These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26522655)

  • 1. Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients.
    Lee YT; Ng HY; Chiu TT; Li LC; Pei SN; Kuo WH; Lee CT
    Clin Chim Acta; 2016 Jan; 452():38-43. PubMed ID: 26522655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
    Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
    Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.
    Wang XR; Yuan L; Zhang JJ; Hao L; Wang DG
    Nephrology (Carlton); 2017 Apr; 22(4):286-292. PubMed ID: 27165564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 is a predictor of aortic artery calcification in maintenance hemodialysis patients.
    Chen Z; Chen X; Xie J; Ma X; Zhong F; Hou L; Ling H; Li X; Ren H; Chen N
    Ren Fail; 2013; 35(5):660-6. PubMed ID: 23581403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sclerostin quo vadis? - is this a useful long-term mortality parameter in prevalent hemodialysis patients?
    Nowak A; Artunc F; Serra AL; Pollock E; Krayenbühl PA; Müller C; Friedrich B
    Kidney Blood Press Res; 2015; 40(3):266-76. PubMed ID: 25997652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Soluble Klotho Level Is Associated with Abdominal Aortic Calcification in Patients on Maintenance Hemodialysis.
    Cai H; Lu R; Zhang M; Pang H; Zhu M; Zhang W; Ni Z; Qian J; Yan Y
    Blood Purif; 2015; 40(2):120-6. PubMed ID: 26159932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis.
    Paccou J; Mentaverri R; Renard C; Liabeuf S; Fardellone P; Massy ZA; Brazier M; Kamel S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4740-8. PubMed ID: 25222755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study.
    Schoppet M; Hofbauer LC; Brinskelle-Schmal N; Varennes A; Goudable J; Richard M; Hawa G; Chapurlat R; Szulc P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E575-83. PubMed ID: 22319041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Risk Factors Including Bone-Derived Biomarkers and Aortic Arch Calcification in Maintenance Hemodialysis Patients.
    Nitta K; Hanafusa N; Okazaki M; Komatsu M; Kawaguchi H; Tsuchiya K
    Kidney Blood Press Res; 2018; 43(5):1554-1562. PubMed ID: 30347400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.
    Asamiya Y; Yajima A; Shimizu S; Otsubo S; Tsuchiya K; Nitta K
    Osteoporos Int; 2015 Mar; 26(3):1017-28. PubMed ID: 25366373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerostin: Another vascular calcification inhibitor?
    Claes KJ; Viaene L; Heye S; Meijers B; d'Haese P; Evenepoel P
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3221-8. PubMed ID: 23788689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels: the STRAMBO study.
    Szulc P; Schoppet M; Rachner TD; Chapurlat R; Hofbauer LC
    J Clin Endocrinol Metab; 2014 Feb; 99(2):617-24. PubMed ID: 24276456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Complement Protein C3a Level Was Associated with Abdominal Aortic Calcification in Patients on Hemodialysis.
    Wang Y; Miao Y; Gong K; Cheng X; Chen Y; Zhao MH
    J Cardiovasc Transl Res; 2019 Oct; 12(5):496-505. PubMed ID: 30989586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of abdominal aortic calcification at different stages of chronic kidney disease.
    Biyik Z; Selcuk NY; Tonbul HZ; Anil M; Uyar M
    Int Urol Nephrol; 2016 Dec; 48(12):2061-2068. PubMed ID: 27620901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis.
    Carlson N; Mortensen OH; Axelsen M; Pedersen RS; Heaf JG
    Blood Purif; 2017; 44(2):122-128. PubMed ID: 28554171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biological determinants of sclerostin plasma concentration in hemodialysis patients.
    Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Bruyère O; Reginster JY; Pottel H; Cavalier E
    Nephron Clin Pract; 2014; 128(1-2):127-34. PubMed ID: 25377055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
    Viaene L; Behets GJ; Claes K; Meijers B; Blocki F; Brandenburg V; Evenepoel P; D'Haese PC
    Nephrol Dial Transplant; 2013 Dec; 28(12):3024-30. PubMed ID: 23605174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.